Dapsone side effects: topical vs oral risks explained

Last updated 2026-07-27

What's the difference between topical and oral dapsone side effects?

Topical dapsone (brand name Aczone, 5% or 7.5% gel) sits on your face. It's FDA-approved for acne and the amount absorbed into your bloodstream is tiny. In the trials submitted to the FDA, blood levels of dapsone after daily gel use came in far below what you'd see from an oral dose, which is exactly why the side effect profile looks so different ^[1]. Oral dapsone is a sulfone antibiotic, dosed in tablets, used for conditions like dermatitis herpetiformis, leprosy (Hansen's disease), and certain cases of severe inflammatory acne that haven't responded to anything else. It's absorbed almost completely and circulates through your whole body, which means it can affect your red blood cells, your liver, your bone marrow, and your immune system, more than your skin ^[2]. Think of it this way: topical dapsone side effects are mostly a skin story. Dryness, redness, a little peeling. Oral dapsone side effects are a blood and organ story (hemolysis, methemoglobinemia, rare but serious hypersensitivity reactions). If an article or a friend tells you "dapsone side effects" without specifying which form, ask which one they mean. It changes everything.

What are the common side effects of topical dapsone (Aczone)?

The most common side effects reported in Aczone's clinical trials were dryness, redness (erythema), and oiliness at the application site, plus occasional peeling. In the phase 3 trials for Aczone 7.5% gel, application site reactions like dryness and erythema occurred in roughly 3 to 6% of patients, similar to or only slightly above the vehicle (placebo gel) group ^[1]. A less common but well-documented quirk: if you use topical dapsone gel around the same time as benzoyl peroxide, you can get a temporary yellow-orange skin discoloration. It's cosmetic, not dangerous, and it fades, but it surprises people. The Aczone label specifically notes this interaction ^[1]. Systemic side effects (the ones that come from dapsone actually getting into your bloodstream) are rare with the gel because so little of it is absorbed. Serious hematologic effects like hemolytic anemia, which are the headline risk with oral dapsone, have not been established as a meaningful risk with the topical formulation in the approved labeling, and G6PD testing is not required before starting the gel ^[1]. Most people who quit using Aczone do it because of dryness or because it just didn't clear their acne well enough, not because of a scary reaction. That's a very different risk conversation than the oral drug.

What are the serious side effects of oral dapsone?

Oral dapsone carries a real list of serious risks, and this is where people researching "dapsone side effects" need to slow down. The major ones, per FDA-reviewed prescribing information, are hemolytic anemia, methemoglobinemia, agranulocytosis, peripheral neuropathy, and dapsone hypersensitivity syndrome (also called sulfone syndrome) ^[2][3]. Hemolytic anemia happens because dapsone's breakdown products oxidize red blood cells. Some degree of hemolysis (red cell breakdown) is expected in most patients taking oral dapsone at standard doses, even those with normal G6PD enzyme activity; it becomes dangerous mainly in people who are G6PD deficient, where it can be sudden and severe ^[2]. Methemoglobinemia is a related but separate problem: dapsone's metabolites convert hemoglobin into a form (methemoglobin) that can't carry oxygen properly. Mild methemoglobinemia is common and often not noticed; higher levels cause cyanosis (bluish skin), fatigue, shortness of breath, and in severe cases can be life-threatening ^[2][3]. Dapsone hypersensitivity syndrome is rarer but serious: fever, rash, and organ involvement (often the liver) typically appearing 2 to 6 weeks after starting the drug. It's a recognized cause of hospitalization and, rarely, death in patients on oral dapsone, which is why prescribers watch closely in the first month or two ^[2]. Agranulocytosis, a dangerous drop in infection-fighting white blood cells, is uncommon but is specifically called out in dapsone's prescribing information as a reason for routine blood monitoring ^[2][3].

Why does oral dapsone require a G6PD test before you start?

Because G6PD (glucose-6-phosphate dehydrogenase) deficiency is the single biggest predictor of who will have a dangerous, rapid hemolytic reaction to oral dapsone. G6PD is an enzyme that protects red blood cells from oxidative damage. People with an inherited deficiency in this enzyme (it's more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, and it's X-linked so it affects men more often) have red cells that are much more vulnerable to drugs like dapsone ^[4]. Standard prescribing guidance calls for checking G6PD status before starting oral dapsone, precisely because giving the drug to someone with severe deficiency can trigger acute hemolysis, sometimes needing transfusion or hospitalization ^[2][4]. This is not an optional precaution. It's a specific, named step in responsible oral dapsone prescribing. If you've been told you're starting oral dapsone and nobody has mentioned a G6PD test, ask directly. It's a simple blood test, not an inconvenience worth skipping. Topical dapsone does not carry this same requirement in its FDA labeling, because so little drug reaches the bloodstream at approved doses ^[1].

Can dapsone cause anemia, and how would I know?

Yes, with oral dapsone, some degree of hemolytic anemia is expected and dose-related, even in people with normal G6PD levels; it just tends to be mild and manageable in that group and monitored via routine bloodwork ^[2]. In people with G6PD deficiency, it can be abrupt and severe. Watch for fatigue, unusual paleness, shortness of breath, dark urine, or a rapid heartbeat while on oral dapsone. These are classic hemolysis symptoms and warrant a call to your prescriber and often same-day labs (a complete blood count and reticulocyte count) ^[2]. Topical dapsone has not been shown to cause clinically meaningful anemia in its approved trials, again because the systemic dose is so low ^[1]. If you're only using the 5% or 7.5% gel on your face for acne, anemia monitoring isn't part of the standard protocol.

What is methemoglobinemia and how serious is it with dapsone?

Methemoglobinemia is a condition where hemoglobin gets chemically altered so it can't release oxygen to your tissues properly, even though your oxygen saturation reading might look deceptively okay on a standard pulse oximeter. With oral dapsone, mild elevations in methemoglobin are common and often asymptomatic ^[2][3]. Higher levels cause a grayish-blue tint to the lips and fingertips (cyanosis), headache, dizziness, fast heart rate, and in severe cases confusion or chest pain. This is treated with methylene blue in more serious cases, and prescribers managing oral dapsone are trained to watch for these signs, especially early in treatment or after a dose increase ^[2][3]. This risk is specific to the oral, systemic form of the drug. It is not a documented concern with topical Aczone at labeled doses, because the amount of drug reaching your blood is a small fraction of what an oral tablet delivers ^[1].

What is dapsone hypersensitivity syndrome?

Dapsone hypersensitivity syndrome (sometimes grouped with drug reaction with eosinophilia and systemic symptoms, or DRESS) is a delayed, serious reaction to oral dapsone. It typically shows up 2 to 6 weeks after starting the drug, with fever, a spreading rash, swollen lymph nodes, and liver inflammation (hepatitis) being the classic triad ^[2]. It's uncommon, but it's serious enough that it's specifically named in dapsone's prescribing information as a reason for close early monitoring, and it can require hospitalization and stopping the drug immediately ^[2]. Liver failure and death have been reported in severe, unrecognized cases, which is part of why oral dapsone isn't a drug people should be self-managing or getting through informal channels. This syndrome has no real counterpart described for topical Aczone in its FDA labeling. It's an oral-drug-specific risk.

Does topical dapsone (Aczone) interact with benzoyl peroxide or other acne products?

Yes, but the interaction is cosmetic, not dangerous. Combining Aczone gel with benzoyl peroxide products can cause a temporary yellow or orange discoloration of the skin and facial hair. It washes off and isn't a sign of a harmful reaction, but the Aczone label calls it out so users aren't caught off guard ^[1]. Beyond that, topical dapsone is generally used alongside standard acne regimens (retinoids, moisturizers, sunscreen) without major documented interaction problems in the approved labeling. If you're layering multiple actives, introduce one at a time so you can tell what's causing any irritation. If you're also curious about how topical or compounded dapsone products get dosed and applied, the Dapsone Rx dosage guide and the Dapsone Rx dosage calculator walk through typical regimens.

Who should not take oral dapsone at all?

People with known G6PD deficiency are the biggest group who need to avoid or very carefully reconsider oral dapsone, given the hemolysis risk ^[2][4]. People with a documented dapsone allergy or prior hypersensitivity syndrome shouldn't be re-challenged. People with significant anemia, active severe infection, or certain liver or bone marrow conditions need extra caution and closer monitoring, decided case by case with a prescriber who's tracking labs. Pregnant and breastfeeding patients need a specific risk conversation with their prescriber, since dapsone crosses into breast milk and neonatal hemolysis and hyperbilirubinemia have been reported in nursing infants of mothers on the drug ^[2]. This is exactly why oral dapsone is a prescription managed with baseline labs and follow-up bloodwork, not a casual acne fix. Topical dapsone doesn't carry this same restriction list in its FDA labeling, which is a big part of why it's the form most acne patients actually end up using ^[1].

How are oral dapsone side effects monitored and managed?

Standard practice for someone starting oral dapsone includes a baseline G6PD test, a complete blood count, and liver function tests, followed by repeat bloodwork on a schedule, often weekly for the first month, then tapering to monthly, though exact intervals vary by prescriber and indication ^[2]. This isn't overkill. It's how hemolysis, methemoglobinemia, and early hypersensitivity syndrome get caught before they become emergencies. If hemoglobin drops sharply, methemoglobin climbs, or liver enzymes spike, the drug typically gets paused or stopped and the patient gets evaluated urgently. Severe hemolysis or methemoglobinemia can require hospitalization, blood transfusion, or methylene blue treatment ^[2][3]. This level of monitoring is a strong signal about how oral dapsone should be treated: as a serious systemic medication requiring an ongoing prescriber relationship, not a one-time purchase.

Is topical dapsone safe for long-term daily acne use?

For most people, yes, topical dapsone gel is considered safe for ongoing daily use as directed, and it's approved for patients 12 years and older with acne vulgaris ^[1]. The FDA's approval of Aczone 7.5% gel was based on 12-week trials in which the medication was generally well tolerated, with local skin reactions as the main complaint ^[1]. That said, "safe for long-term use" doesn't mean "guaranteed to work for you." Some people see meaningful improvement in inflammatory acne lesions over 12 weeks; others get more modest results and end up combining it with a retinoid or antibiotic under a dermatologist's plan. If dryness gets uncomfortable, cutting back to every-other-day application or pairing it with a simple moisturizer usually helps. If you're using a provider-prescribed formulation and want a clear picture of dosing frequency and duration, Dapsone Rx dosage and Dapsone Rx cycle length cover that ground in more detail.

Where does Dapsone fit into getting dapsone safely?

Dapsone Rx doesn't manufacture or compound anything. It connects patients researching dapsone with a provider-reviewed pathway, so any prescription, whether topical or oral, goes through a licensed prescriber who can order the right labs (including G6PD testing before oral dapsone) and a licensed pharmacy partner handles the actual fulfillment ^[2][4]. That structure matters specifically because of everything above: the gap between "mild dryness from a gel" and "hemolytic anemia from a systemic antibiotic" is enormous, and it's not a gap you want to navigate without someone checking labs first. A provider-reviewed process is what makes sure the G6PD test happens before the prescription, not after a problem shows up. If you're further along and thinking about administration specifics for an injectable or compounded product, see how to reconstitute Dapsone Rx, Dapsone Rx how to inject, and Dapsone Rx injection sites for the practical mechanics, alongside your prescriber's specific instructions.

Frequently asked questions

What are the most common side effects of Aczone (topical dapsone)?

Dryness, redness, and mild peeling at the application site are the most commonly reported side effects in Aczone's clinical trials, occurring in roughly 3 to 6% of users at rates close to placebo gel. Serious systemic reactions are not established as a meaningful risk with the topical form at approved doses ^[1].

Does topical dapsone require a G6PD test?

No. FDA labeling for Aczone (topical dapsone gel) does not require G6PD testing before use, because absorption into the bloodstream is very low at approved doses ^[1]. G6PD testing is specifically required before starting oral dapsone, which is a systemic drug with real hemolysis risk ^[2][4].

Can dapsone gel cause skin discoloration?

Yes, but it's temporary and harmless. Using Aczone gel together with benzoyl peroxide products can cause a yellow or orange tint on skin and facial hair, which washes off. It's a cosmetic interaction noted directly in the product labeling, not a safety concern ^[1].

What happens if someone with G6PD deficiency takes oral dapsone?

They're at high risk for acute, severe hemolytic anemia, since dapsone's metabolites oxidize red blood cells and G6PD-deficient cells can't defend against that oxidative stress. This can require hospitalization or transfusion, which is exactly why baseline G6PD testing is standard before starting oral dapsone ^[2][4].

Is oral dapsone ever used for acne?

It's used off-label in some severe, treatment-resistant inflammatory acne cases, but it's not a first-line or casual option because of hemolysis, methemoglobinemia, and hypersensitivity syndrome risks. Topical dapsone (Aczone) is the FDA-approved, lower-risk option most acne patients actually use ^[1][2].

How soon do dapsone hypersensitivity syndrome symptoms appear?

Typically 2 to 6 weeks after starting oral dapsone, presenting with fever, rash, swollen lymph nodes, and liver inflammation. It's uncommon but serious enough that prescribers monitor closely during this window and it's specifically flagged in dapsone's prescribing information ^[2].

Can topical dapsone cause anemia?

Clinically meaningful anemia has not been established as a risk of topical Aczone in its FDA trials, largely because systemic absorption is minimal. Oral dapsone, by contrast, causes some degree of hemolysis in nearly all users and can cause severe anemia in G6PD-deficient patients ^[1][2].

What blood tests are needed before starting oral dapsone?

Standard baseline testing includes a G6PD level, complete blood count, and liver function tests, followed by periodic repeat labs (often weekly at first, then less frequent) to catch hemolysis, methemoglobinemia, or liver problems early ^[2].

Is methemoglobinemia reversible?

Mild methemoglobinemia from dapsone often resolves on its own once the drug is stopped or the dose is lowered. Severe cases are treated with methylene blue and require prompt medical attention; untreated severe cases can be life-threatening ^[2][3].

Can you use topical dapsone if you're G6PD deficient?

Topical Aczone's FDA labeling doesn't include a G6PD restriction, since systemic absorption is low, but anyone with known G6PD deficiency considering any dapsone product should still tell their prescriber, especially before any oral dapsone use ^[1][2].

How is oral dapsone hemolysis different from methemoglobinemia?

Hemolysis is the breakdown of red blood cells themselves, causing anemia, fatigue, and dark urine. Methemoglobinemia is a change in hemoglobin's chemistry that impairs oxygen delivery, causing cyanosis and low functional oxygenation. Oral dapsone can cause both, sometimes together, which is why bloodwork checks for each separately ^[2][3].

Does dapsone interact badly with other medications?

Oral dapsone has recognized interactions, including with trimethoprim (can increase levels of both drugs) and rifampin (can lower dapsone levels), among others, so a full medication review with your prescriber matters before starting it. Topical dapsone has far fewer documented systemic interactions given its minimal absorption ^[2][1].

Sources

1. FDA, Aczone (dapsone) Gel, 7.5% prescribing information: Topical dapsone's common side effects, benzoyl peroxide discoloration interaction, and low systemic absorption
2. DailyMed, Dapsone Tablets USP prescribing information (Jacobus Pharmaceutical): Oral dapsone's hemolysis, methemoglobinemia, agranulocytosis, hypersensitivity syndrome risks and monitoring/G6PD guidance
3. MedlinePlus, Methemoglobinemia: Description and symptoms of methemoglobinemia including cyanosis and severity spectrum
4. CDC, Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: G6PD deficiency background, inheritance pattern, and population prevalence context
5. MedlinePlus, Dapsone: Patient-facing summary of oral dapsone's serious side effects and monitoring needs